e-Article
5q+ MDS Patients with Low RPS14 Expression Are Candidates to Immune-Modulating Drugs
Document Type
Article
Author
Source
Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p5303-5303, 1p
Subject
Language
ISSN
00064971; 15280020
Abstract
Introduction